Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.
about
Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoniA systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoniSchistosomiasis vaccinesT follicular helper cells differentiate from Th2 cells in response to helminth antigensHuman hookworm infection in the 21st centuryChanges in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantelAre basophils important mediators for helminth-induced Th2 immune responses? A debateIgE immunotherapy against cancerCore alpha1-->3-fucose is a common modification of N-glycans in parasitic helminths and constitutes an important epitope for IgE from Haemonchus contortus infected sheepAnalysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: the influence of age, sex, ethnicity and IgEObserved reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling studyIL-10 blocks the development of resistance to re-infection with Schistosoma mansoniPredicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobiumHost determinants of reinfection with schistosomes in humans: a systematic review and meta-analysisParamyosin is a major target of the human IgA response against Schistosoma japonicum.Age-adjusted Plasmodium falciparum antibody levels in school-aged children are a stable marker of microgeographical variations in exposure to Plasmodium infection.Developmentally regulated expression, alternative splicing and distinct sub-groupings in members of the Schistosoma mansoni venom allergen-like (SmVAL) gene family.Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trialImmunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection.Human IgE responses to different splice variants of Schistosoma mansoni tropomyosin: associations with immunity.Differential expression of anti-glycan antibodies in schistosome-infected humans, rhesus monkeys and miceImmune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems.Association of schistosomiasis with false-positive HIV test results in an African adolescent population.Development of antibody isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: influence of infection duration, infection intensity, and host age.In vivo imaging of tissue eosinophilia and eosinopoietic responses to schistosome worms and eggsEffect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomized, placebo-controlled trial.Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century.Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.Interleukin 5 (IL-5) is not required for expression of a Th2 response or host resistance mechanisms during murine schistosomiasis mansoni but does play a role in development of IL-4-producing non-T, non-B cells.Human immune responses to Schistosoma mansoni vaccine candidate antigens.Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapyImmunology of parasitic helminth infections.The Schistosoma mansoni tegumental-allergen-like (TAL) protein family: influence of developmental expression on human IgE responses.Suppression of basophil histamine release and other IgE-dependent responses in childhood Schistosoma mansoni/hookworm coinfection.Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins.T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum.Immunity in humans to Necator americanus: IgE, parasite weight and fecundity.Helminth infection in populations undergoing epidemiological transition: a friend or foe?The Schistosoma mansoni phylome: using evolutionary genomics to gain insight into a parasite's biologyDifferential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray.
P2860
Q21092289-DF520CA4-0AB8-4F39-8298-520BB897A459Q21144505-4AD862C2-2919-4D11-97BB-1201D9E1D580Q24598949-6FB65A37-8037-4164-9E81-A7C47BED3C48Q24645365-21C65670-DA67-4B55-AF89-496B58D84062Q24652391-5D8EAECA-D518-44B5-948F-295B0C654FE2Q24802984-2308FB49-B740-4469-BF36-030CA8D79D96Q26865224-6FA446BE-2E90-4D93-BCA3-A0340AFC8B5FQ28081223-77CF0A21-8103-46A2-9149-975AED18F4C0Q28377706-8DF3E6CB-8190-441F-BBA5-BA66B0CACA51Q28475501-0ECFE2E8-E729-4E75-88DE-18CFFA9F47AFQ28476209-FCA59084-6CA7-46E9-A525-60DE75366905Q28476429-FBCE2409-8296-4C5F-B9B6-1E795A5DDF2DQ28541406-6C9B3D17-2551-4D99-B068-E607B4E1C91CQ28542932-D8B969C6-B074-4CD5-862B-77EB3D5661ADQ30822008-FC48EBCB-819B-4C29-9803-B42B4CC56B7FQ33289532-65290D3A-684C-4B96-87EF-15F786DEBB65Q33320897-54DDA382-6C20-422A-823E-06B8E84F492CQ33419492-29B2EF93-3E22-4F91-BA1C-E9C3EA2BB64DQ33615961-6D0F4308-D430-46B8-9877-CFCA61676E10Q33634824-9D7E0130-39F4-42FC-9FEA-4C7F7787CD73Q33684613-A39174A0-B167-4319-8D9D-6D44FF4AF1C6Q33696522-55DAC005-F146-47B9-8903-AB0DE381D4A3Q33827223-C76585F5-E5BE-4FF6-984A-9778A137CD2AQ33876836-690CD052-FE42-43A7-BF29-98D30B98B2AAQ33937006-1B8CE6AC-300C-4DFE-880D-A5F1DDB61A54Q33941725-ABEF3D50-99DB-4408-952C-99380C5A7375Q33941727-E937D7EF-B34C-475D-BEB7-C54B31E24ACCQ33965354-21F3789D-BEC5-40B9-B9BE-E7FB15B2270EQ34001182-6574C9D2-2797-488B-942C-331011D9DBADQ34004360-2D225DB3-62E8-485D-8072-2EF9E265970CQ34005571-03D8804D-0271-4168-94D7-9CB4BA032526Q34116840-E643FA2E-C849-4478-842C-4D5AF643E4A3Q34235698-E0CB0854-DF08-409D-AED7-A949E36CDBCFQ34249973-B2207BA6-D541-4EA2-BA09-D0368136A3FBQ34256750-B5D06E4C-41F3-4BC9-B542-BE0564638F3BQ34301170-54C12DD1-0902-47F9-AA9B-201494FE19E1Q34311535-01435DE6-787A-4A11-B840-465B709391ACQ34467996-4DDD20FD-4EBB-43EA-B1E0-8468EA4ECED2Q34475796-4EBC5C53-E267-4E70-8D2D-6D372596ACB6Q34500892-675CCFF8-313C-43F1-9005-F049B4AC9F42
P2860
Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Immunity after treatment of hu ...... and resistance to reinfection.
@en
Immunity after treatment of hu ...... and resistance to reinfection.
@nl
type
label
Immunity after treatment of hu ...... and resistance to reinfection.
@en
Immunity after treatment of hu ...... and resistance to reinfection.
@nl
prefLabel
Immunity after treatment of hu ...... and resistance to reinfection.
@en
Immunity after treatment of hu ...... and resistance to reinfection.
@nl
P2093
P921
P356
P1476
Immunity after treatment of hu ...... and resistance to reinfection.
@en
P2093
Butterworth AE
Fulford AJ
Kariuki HC
Langley JG
Sturrock RF
P304
P356
10.1002/EJI.1830220622
P407
P577
1992-06-01T00:00:00Z